| Date | Form | Description | Docs | XBRL | Pages |
| 11/17/17 | 8-K | Current report filing |
|
48 | |
| 11/17/17 | 424B5 | Prospectus filed pursuant to Rule 424(b)(5) |
|
45 | |
| 10/26/17 | EFFECT | Notice of Effectiveness |
|
1 | |
| 10/24/17 | CORRESP | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. |
|
1 | |
| 10/23/17 | UPLOAD | SEC-generated letter |
|
2 | |
| 10/23/17 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 10/16/17 | S-3 | Registration statement for specified transactions by certain issuers |
|
30 | |
| 10/03/17 | 8-K | Current report filing |
|
4 | |
| 10/02/17 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 10/02/17 | 3 | Initial statement of beneficial ownership of securities |
|
2 |
Latest News & Events
Anixa Biosciences Expands Partnership with Cleveland Clinic to Develop Additional Cancer Vaccines
Read More...Anixa Biosciences CEO Featured on "Target: Cancer Podcast" by Oncologist Dr. Sanjay Juneja
Read More...Anixa Biosciences to Participate in the Sidoti Micro-Cap Virtual Conference on May 8 & 9, 2024
Read More...